Trimetazidine as an Adjunct to Enhance Clopidogrel Response.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
Hypothesis: Trimetazidine improves Clopidogrel response in patients. • The investigators postulate that the inhibition of platelet aggregation in response to Clopidogrel may be accentuated by Trimetazidine, i.e. Trimetazidine enhances Clopidogrel response. Null Hypothesis: There is no difference in Clopidogrel response in patients with stable coronary artery disease with adjunctive Trimetazidine.
Epistemonikos ID: 931bbf6ca4292bd6f321f4cf0b08aed17b4a543c
First added on: May 21, 2024